Los registros los proporcionan patrocinadores e investigadores. Estar en el registro no garantiza seguridad, disponibilidad ni elegibilidad, ni representa un aval. Los títulos, resúmenes y criterios originales del registro se muestran en inglés para conservar su significado.
Listado de WCR consultado: 12 nov 2026.
ReclutandoNCT06515613
Platinum-resistant Ovarian Cancer · Testicular Cancer · Endometrial Cancer
Fase 118 años - No especificadoLittle Rock, Arkansas, United States +14 This is a Phase 1a/1b, open-label, dose escalation and expansion study to evaluate the safety and efficacy of CTIM-76 (study drug), a CLDN6-directed T cell-engaging bispecific antibody , in participants with platinum-refractory/resistant ovarian canc…
CompletadoNCT02363335
Healthy Volunteers
Fase 121 años - 55 añosBaltimore, Maryland, United States Background: The drug Roflumilast (Daliresp) is used to treat Chronic Obstructive Pulmonary Disease (COPD). COPD is a lung disease that makes it difficult to breathe. Studies have shown that this drug decreased the blood sugar of people with type 2 di…
Activo, sin reclutamientoNCT06565455
Pediatric Obesity · Health Behavior, Risky
No aplica7 años - No especificadoLittle Rock, Arkansas, United States Childhood obesity is a national problem with racial and ethnic disparities specifically among Hispanic children. The primary purpose of this study is to develop and implement a culturally appropriate healthy eating intervention called Growing Healthy…
ReclutandoNCT06730126
Autoimmune Lymphoproliferative Syndrome
Fase 216 años - 120 añosBethesda, Maryland, United States +2 Background: Autoimmune lymphoproliferative syndrome (ALPS) is a rare disorder of the immune system caused by a mutation in the FAS gene. In ALPS, the body stores too many germ-fighting cells called lymphocytes. This can lead to an enlarged spleen and…
Aún no reclutaNCT07927491
Recurrent Glioblastoma With EGFR Mutation
Fase 118 años - No especificadoBoston, Massachusetts, United States +2 This is an open-label, first-in-human phase 1 and surgical window of opportunity study designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary anti-tumor activity of CM93 in subjects with recurrent glioblasto…
No divulgadoNCT07930052
No informadoNo especificado - No especificadoUbicación no indicada ReclutandoNCT07555938
Multiple Myeloma
Fase 318 años - No especificadoDuarte, California, United States +93 The purpose of this study is to assess the efficacy and safety of cevostamab in combination with pomalidomide and dexamethasone (CevosPd) versus standard of care (SOC) in participants with multiple myeloma (MM) who have received one to three prior li…
CompletadoNCT07439185
Gut -Microbiota · Inflamation · Iron Absorption
No aplica9 años - 13 añosAntsirabe, Vakinankaratra Region, Madagascar The purpose of this study is to determine the health impacts of consistent consumption of insect-fortified crackers among school-aged children in Madagascar. Specifically, in this RCT, the investigators will assess whether the insect-fortified cracke…
Activo, sin reclutamientoNCT02584244
Colorectal Cancer · Pancreatic Cancer · Esophageal Cancer · Gastric Cancer
Fase 1 / Fase 218 años - No especificadoBoston, Massachusetts, United States The overall goal of this feasibility study is to assess the initial safety and efficacy of LUM015 in ex vivo far-red imaging of colorectal, pancreatic, and esophageal cancers (adenocarcinoma) using the LUM Imaging System.
CompletadoNCT05726136
Colorectal Cancer · Urologic Cancer · Gynecologic Cancer · Colorectal Disorders · Benign Neoplasm
Fase 418 años - 85 añosNorrköping, Östergötland County, Sweden A short bolus infusion of fluid, called "fluid challenge" is commonly recommended for fluid treatment during longer surgery. However a prolonged increase of the blood volume is a prerequisite to recommend the technique. The purpose with the study is …
ReclutandoNCT07540221
CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy)
Fase 318 años - No especificadoRancho Mirage, California, United States +14 The main goal of the study is to find out whether XEMBIFY, given once a week under the skin, provides similar levels of immunoglobulin G in the blood over time as Gamunex-C, which is given into a vein once every 3 weeks in people with CIDP. Participa…
ReclutandoNCT06219863
Down Syndrome
No aplicaNo especificado - 2 añosBoston, Massachusetts, United States The emergence of crawling and walking is significantly delayed in infants with Down syndrome (DS), but the development of independent mobility provides infants with new opportunities for exploring the environment and interacting with objects and peop…
Consultado en ClinicalTrials.gov: 12 nov 2026. El estado general puede ser distinto al de un centro específico.
